What is the address of DR. MAUDENS GUNTHER - CARDIOLOOG?

The registered office of DR. MAUDENS GUNTHER - CARDIOLOOG is located at Maelbroekstraat 15, 9230 Wetteren.

Is DR. MAUDENS GUNTHER - CARDIOLOOG still active?

Yes. According to the CBE (18 September 2026) DR. MAUDENS GUNTHER - CARDIOLOOG is active, legal situation “Normale toestand”, started on 23 November 2010.

Is DR. MAUDENS GUNTHER - CARDIOLOOG registered on Peppol?

No, DR. MAUDENS GUNTHER - CARDIOLOOG is currently not registered on the Peppol network.

What is the enterprise number of DR. MAUDENS GUNTHER - CARDIOLOOG?

The enterprise number of DR. MAUDENS GUNTHER - CARDIOLOOG is BE0831285644.

When was DR. MAUDENS GUNTHER - CARDIOLOOG founded?

DR. MAUDENS GUNTHER - CARDIOLOOG was founded on 23 November 2010.

Who are the directors of DR. MAUDENS GUNTHER - CARDIOLOOG?

According to the 2025 annual accounts, the directors of DR. MAUDENS GUNTHER - CARDIOLOOG are: Günther Maudens.

Is DR. MAUDENS GUNTHER - CARDIOLOOG a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 23 November 2010; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. MAUDENS GUNTHER - CARDIOLOOG make in 2025?

DR. MAUDENS GUNTHER - CARDIOLOOG posted a profit after taxes of € 150,080 in financial year 2025.

What is the revenue of DR. MAUDENS GUNTHER - CARDIOLOOG?

As a small company, DR. MAUDENS GUNTHER - CARDIOLOOG is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 250,611.

DR. MAUDENS GUNTHER - CARDIOLOOG (Private Limited)

Dossier DR. MAUDENS GUNTHER - CARDIOLOOG, printed on 18 September 2026 from databakkes.be/en/0831285644/dr-maudens-gunther-cardioloog. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

DR. MAUDENS GUNTHER - CARDIOLOOG from Wetteren, company number BE0831285644, closed financial year 2025 with a result of € 150,080 after tax. For that financial year DR. MAUDENS GUNTHER - CARDIOLOOG recorded a gross margin of € 250,611 and equity of € 302,879. Compared with financial year 2024, the result moved from € 78,056 to € 150,080. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 8, 2025.

What it is worth Healthy

€ 302,879

▼ 34% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 150,080

▲ 92% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 303,436

▲ 84% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 303,088 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 3,357

▼ 29% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 101,884

▼ 33% vs 2024

€ 50,060 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 3,029

▲ 4% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 34,881

▲ € 27,213 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 154,331 Gross margin 2022: € 154,331 First fiscal year in the series	€ 127,006 Gross margin 2023: € 127,006 ▼ 18% vs 2022 (€ 154,331) Unfavourable step	€ 152,083 Gross margin 2024: € 152,083 ▲ 20% vs 2023 (€ 127,006) Favourable step	€ 250,611 Gross margin 2025: € 250,611 ▲ 65% vs 2024 (€ 152,083) Favourable step	▲ 65%
Profit after taxes	€ 79,351 Profit after taxes 2022: € 79,351 First fiscal year in the series	€ 59,777 Profit after taxes 2023: € 59,777 ▼ 25% vs 2022 (€ 79,351) Unfavourable step	€ 78,056 Profit after taxes 2024: € 78,056 ▲ 31% vs 2023 (€ 59,777) Favourable step	€ 150,080 Profit after taxes 2025: € 150,080 ▲ 92% vs 2024 (€ 78,056) Favourable step	▲ 92%
Equity	€ 452,339 Equity 2022: € 452,339 First fiscal year in the series	€ 482,878 Equity 2023: € 482,878 ▲ 7% vs 2022 (€ 452,339) Favourable step	€ 455,887 Equity 2024: € 455,887 ▼ 6% vs 2023 (€ 482,878) Unfavourable step	€ 302,879 Equity 2025: € 302,879 ▼ 34% vs 2024 (€ 455,887) Unfavourable step	▼ 34%
Total debts	€ 321,000 Total debts 2022: € 321,000 First fiscal year in the series	€ 235,839 Total debts 2023: € 235,839 ▼ 27% vs 2022 (€ 321,000) Favourable step	€ 267,699 Total debts 2024: € 267,699 ▲ 14% vs 2023 (€ 235,839) Unfavourable step	€ 442,882 Total debts 2025: € 442,882 ▲ 65% vs 2024 (€ 267,699) Unfavourable step	▲ 65%
Cash	€ 237,367 Cash 2022: € 237,367 First fiscal year in the series	€ 91,445 Cash 2023: € 91,445 ▼ 61% vs 2022 (€ 237,367) Unfavourable step	€ 164,648 Cash 2024: € 164,648 ▲ 80% vs 2023 (€ 91,445) Favourable step	€ 303,436 Cash 2025: € 303,436 ▲ 84% vs 2024 (€ 164,648) Favourable step	▲ 84%
Land & buildings	€ 1,034 Land & buildings 2022: € 1,034 First fiscal year in the series	€ 815 Land & buildings 2023: € 815 ▼ 21% vs 2022 (€ 1,034) Unchanged	€ 595 Land & buildings 2024: € 595 ▼ 27% vs 2023 (€ 815) Unchanged	€ 376 Land & buildings 2025: € 376 ▼ 37% vs 2024 (€ 595) Unchanged	▼ 37%
Retained profit	€ 439,939 Retained profit 2022: € 439,939 First fiscal year in the series	€ 470,478 Retained profit 2023: € 470,478 ▲ 7% vs 2022 (€ 439,939) Favourable step	€ 443,487 Retained profit 2024: € 443,487 ▼ 6% vs 2023 (€ 470,478) Unfavourable step	€ 290,479 Retained profit 2025: € 290,479 ▼ 35% vs 2024 (€ 443,487) Unfavourable step	▼ 35%
Dividend	€ 200,766 Dividend 2022: € 200,766 First fiscal year in the series	€ 29,238 Dividend 2023: € 29,238 ▼ 85% vs 2022 (€ 200,766) Unchanged	€ 105,048 Dividend 2024: € 105,048 ▲ 259% vs 2023 (€ 29,238) Unchanged	€ 303,088 Dividend 2025: € 303,088 ▲ 189% vs 2024 (€ 105,048) Unchanged	▲ 189%
Bank debt	€ 247,176 Bank debt 2022: € 247,176 First fiscal year in the series	€ 199,053 Bank debt 2023: € 199,053 ▼ 19% vs 2022 (€ 247,176) Favourable step	€ 150,951 Bank debt 2024: € 150,951 ▼ 24% vs 2023 (€ 199,053) Favourable step	€ 101,884 Bank debt 2025: € 101,884 ▼ 33% vs 2024 (€ 150,951) Favourable step	▼ 33%
Balance sheet total	€ 773,339 Balance sheet total 2022: € 773,339 First fiscal year in the series	€ 718,717 Balance sheet total 2023: € 718,717 ▼ 7% vs 2022 (€ 773,339) Unchanged	€ 723,586 Balance sheet total 2024: € 723,586 ▲ 1% vs 2023 (€ 718,717) Unchanged	€ 745,761 Balance sheet total 2025: € 745,761 ▲ 3% vs 2024 (€ 723,586) Unchanged	▲ 3%

Key figures of DR. MAUDENS GUNTHER - CARDIOLOOG, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to DR. MAUDENS GUNTHER - CARDIOLOOG?

What happened at DR. MAUDENS GUNTHER - CARDIOLOOG in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 8, 2025 New annual accounts for financial year 2025: profit of € 150,080 (▲ 92% vs 2024). Source: NBB ↗
Nov 23, 2010 New establishment in Wetteren. KBO
Nov 23, 2010 Start of the company according to the CBE. KBO

In short

From € 79,351 profit in 2022 to € 150,080 profit in 2025.

Paid € 159,274 in corporate taxes since 2022.

Best year ever: 2025, with € 150,080 profit.

Paid out € 638,139 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. MAUDENS GUNTHER - CARDIOLOOG? We notify you, reason included.

Follow DR. MAUDENS GUNTHER - CARDIOLOOG

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Günther Maudens

DR. MAUDENS GUNTHER - CARDIOLOOG

Behind DR. MAUDENS GUNTHER - CARDIOLOOG is Günther Maudens.

See the full network in the app

Directors

According to the 2025 annual accounts

Günther Maudens

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Maelbroekstraat 15

9230 Wetteren

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0831.285.644
VAT number: BE 0831.285.644
Registered office: Maelbroekstraat 15, 9230 Wetteren
Names & denominations: DR. MAUDENS GUNTHER - CARDIOLOOG
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 23 November 2010
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗